Petrus Pharmaceuticals

Petrus Pharmaceuticals is an Australian specialty pharmaceutical company that focuses on the acquisition, licensing, and commercialization of branded and generic medicines. Founded in Australia, the company built a diverse portfolio of products across therapeutic areas such as dermatology, anti-infectives, and pain management. In 2014, Petrus was acquired by Mayne Pharma, a move that significantly expanded Mayne's domestic product offering and market presence in Australia. Today, the Petrus brand continues to represent a range of established pharmaceutical products within the Mayne Pharma portfolio. The company's business model historically centered on revitalizing mature brands through targeted marketing and distribution strategies.